Before you spend your first Japan launch with the wrong operating partner.
A Japanese company has offered to launch your product on Makuake, GREEN FUNDING or another crowdfunding platform. The proposal may be genuinely attractive: temporary exclusivity, no meaningful pre-launch MOQ, and little or no upfront Japan-launch cost for you.
The question is not whether crowdfunding is a good idea. The question is whether this is the right company to become your product's first Japan operator — and how much of what comes next you should entrust to them.
The exclusivity may last only a few months. Your first Japan launch lasts much longer.
A crowdfunding-first proposal can feel like a low-risk test. That is precisely why manufacturers can move too quickly.
“We handle everything.”
The partner may fund localization, campaign production, promotion and operations, while asking you to supply only after demand is confirmed.
“There is no pre-launch MOQ.”
That can be commercially attractive. It also means you may have very little financial reason to slow down and investigate the partner deeply.
“It is only for the campaign.”
Temporary crowdfunding exclusivity can still make this company the operator that creates your product's first Japan-market footprint.
Once the product enters Japan, it begins creating price history, positioning, search results, a crowdfunding record, first customer expectations, Japanese creative assets and the first layer of market knowledge.
You can change partners later. You cannot simply reset the clock and recreate the same first launch.
¥10 million or ¥30 million raised does not answer the question that matters next.
Crowdfunding performance is launch evidence. It is not, by itself, proof of durable distribution capability.
Headline numbers can hide very different demand
¥10 million from roughly 1,000 supporters buying a ¥10,000-class product is commercially different from ¥10 million generated by roughly 10 supporters buying a ¥1 million-class product.
A good launch can still lead nowhere
The important follow-up is whether the product continued selling through ecommerce, wholesale, retail, repeat inventory orders and ongoing marketing after the campaign.
What you may discover too late
- The partner is strong at crowdfunding launches but weak at ongoing distribution.
- Past products largely disappeared after the campaign period.
- The planned retail price does not support attractive ongoing economics for the Japanese operator.
- Inventory investment, repeat orders or channel expansion slow after crowdfunding.
- The Japan domain, social accounts or creative files are controlled by the original operator.
- The brand never built a direct, consent-based relationship with its first Japanese customers.
- A replacement partner must rebuild part of the Japan entry instead of building on what already exists.
We investigate the company behind the proposal — not just the proposal they sent you.
| Review area | What it helps you decide |
|---|---|
| Partner capability | Whether the operator appears capable of more than running the crowdfunding campaign itself. |
| Crowdfunding performance context | What headline support totals mean once supporter count, price points, reward structure and campaign context are considered. |
| Past Product Persistence | What happened to up to 10 products after their launch period, including visible non-crowdfunding sales and channel continuity. |
| Price & post-CF distribution reality | Whether pricing and channel evidence support a viable next stage after crowdfunding. |
| Commercial commitment | Whether cost, inventory risk, purchases, marketing and performance commitments are proportionate to the rights requested. |
| Asset / customer continuity | Whether Japan-facing assets and direct customer relationships remain usable if the operating partner changes. |
| Rights-to-Capability Fit | How much of Japan the available evidence supports entrusting to this company now — and what should wait. |
We do not automatically treat information that cannot be found publicly as negative. We distinguish verified positive, verified negative and unverified evidence.
Not “Is this company trustworthy?” — but “What should we actually let them do?”
PROCEED
The proposed commercial scope appears proportionate to the evidence and commitment.
PROCEED WITH CONDITIONS
The opportunity looks reasonable if specific commercial conditions are added or clarified.
NARROW THE RIGHTS
The partner may be suitable, but the requested or expected scope is broader than demonstrated capability.
TRIAL FIRST
The operator may be promising, but the evidence base is too limited for broader rights today.
COMPARE ALTERNATIVES
The proposal may be viable, but comparison with another Japan option is commercially sensible.
DO NOT GRANT EXCLUSIVITY
The available commercial evidence does not support the requested exclusivity.
Want to see what the analysis looks like? View the Sample Decision Report →
A decision package built for one live Japan proposal.
Standard scope: 1 overseas manufacturer × 1 Japanese candidate × 1 proposal. If you have offers from 2 or 3 Japanese companies, each candidate can be reviewed separately in the same purchase flow.
Executive Decision Report
Clear recommendation, reasoning, capability assessment, key risks and recommended commercial structure.
Evidence Appendix
Source trail, verification notes, product-level evidence and confidence levels.
Commercial Negotiation Sheet
What the partner is asking for versus the commercial structure we recommend.
Findings Call + 30-Day Support
Reasonable follow-up on the same partner and proposal, including revised MOQ, exclusivity, channel, duration and inventory terms.
Designed to fit a live commercial decision.
We can assess whether a five-year term, zero minimum purchase or all-channel scope is commercially excessive relative to the evidence. We do not tell you whether a clause is legally valid or enforceable.
US$3,000 per Japanese candidate × proposal.
- Independent commercial investigation and assessment
- Up to 10 past-product persistence checks
- Crowdfunding performance context and Price Reality Check where verifiable
- Executive Decision Report + Evidence Appendix
- Commercial Negotiation Sheet
- Findings call + 30-day commercial decision support
Current scope and fee may change as the service and evidence database develop. Pharmaceuticals and medical devices are outside the standard scope. This is a commercial assessment; we do not provide legal or regulatory certification or determine whether a product satisfies Japan market-access requirements.
This is for a specific proposal in front of you — not general Japan consulting.
Good fit
- A Japanese importer, crowdfunding operator or distributor has contacted you.
- You are considering a Makuake / GREEN FUNDING / other crowdfunding-first entry.
- The offer looks attractive but you cannot independently verify the company's track record.
- You want to know what should happen after the campaign before the first launch begins.
- You need an independent commercial view before granting or expanding Japan rights.
- You want to assess whether the proposed partner appears capable of building or securing the import, sales and distribution setup needed for the product.
Not the right service
- You need legal contract drafting or a legal opinion.
- You need accounting, tax, regulatory certification or a legal determination of licensing, registration, approval or product-compliance requirements.
- The product is a pharmaceutical or medical device.
- You want us to recruit or search for a Japan distributor as part of this review.
- You want us to operate crowdfunding, Amazon, advertising, importing or logistics.
- You are investigating litigation, private individuals or criminal matters.
Common questions
Is crowdfunding itself the problem?
No. Crowdfunding can be an excellent first step into Japan. The issue is treating a temporary campaign as if the partner choice were equally temporary.
Does a large Makuake result prove the company is a strong distributor?
No. It proves something about the launch. We look at supporter context, product price, what happened to older products, current channels, repeat activity and visible post-crowdfunding persistence.
What if the Japanese company is small or operated by one person?
Small size is not an automatic negative. The question is whether the requested scope matches the capability, workload, financing and continuity that can actually be demonstrated.
Do you require the partner to have an MOQ?
No. Zero pre-launch MOQ can be a very attractive structure when the Japanese partner is funding meaningful launch work and carrying other risks. We assess the balance of cost, risk, rights and commitment.
Can you review a draft distribution agreement?
We can extract and assess commercial terms such as SKU scope, duration, MOQ, minimum purchases, channel scope, sales targets, inventory commitments and renewal conditions. We do not provide legal interpretation, drafting or enforceability opinions.
What if information about the partner is not publicly available?
We label it as unverified rather than automatically scoring it as a failure. Where useful, the report will identify evidence you should request directly from the partner before deciding.
We received offers from more than one Japanese company. Can you review multiple candidates?
Yes. The fee is US$3,000 per Japanese candidate × proposal. You can select 2 or 3 candidates in the payment section and submit the corresponding proposal for each candidate after payment.
Can you review products that have Japan regulatory requirements?
Usually, yes. We can assess whether the proposed Japanese partner appears capable of building or securing the import, sales and distribution setup needed for the product, and we can flag regulatory readiness as a commercial issue. We do not certify compliance or provide a legal or regulatory opinion. Pharmaceuticals and medical devices are outside the standard scope.
What does the 30-day support cover?
Reasonable follow-up on the same Japanese company and the same commercial proposal: revised exclusivity, SKU scope, duration, MOQ, inventory, sales targets, channel structure and whether new evidence changes the recommendation.
This could be a great opportunity. Make sure the deal is as good as the opportunity.
If a Japanese company is about to become the first operator to introduce your product to Japan, verify the company, the launch history and what happens next before you hand over the first launch.